Clinical trial
Inhaled Furosemide for Transient Tachypnea of Newborn
NCT04397991 is registered in ClinicalTrials.gov with Makassed General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inhaled Furosemide for Transient Tachypnea of Newborn
- Lead sponsor
- Makassed General Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 2, 2020
- Completion date
- August 1, 2021
- Enrollment
- 64 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
respiratory morbidity